Structure and Function of a Serotonin Transporter
血清素转运蛋白的结构和功能
基本信息
- 批准号:8773997
- 负责人:
- 金额:$ 57.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-15 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazoleAdverse effectsAffinityAmphetaminesAntidepressive AgentsAnxietyApplications GrantsAttentionAutistic DisorderBindingBinding SitesCellsChemicalsClinicClinicalCocaineComplexCoupledCouplingCysteineCytoplasmDataDetergentsDeuteriumDiseaseDissociationDrosophila melanogasterDrug DesignDrug resistanceExhibitsFunctional disorderGenetic PolymorphismGoalsHomologous GeneHumanHydrogenInvestigationIon CotransportIonsKineticsLaboratoriesLigandsLightLiposomesMass Spectrum AnalysisMeasuresMembraneMental DepressionModelingMolecularMolecular ConformationMolecular MachinesMovementNeuronsObsessive-Compulsive DisorderOrthologous GeneParoxetinePharmacologyPhospholipidsPlayPreparationProcessProteinsPsychotropic DrugsRegulationRoleSelective Serotonin Reuptake InhibitorSerotoninShapesSignal TransductionSite-Directed MutagenesisStructureSynapsesSynaptic TransmissionTestingTherapeuticVestibuleWorkX-Ray Crystallographyantiportbasecrosslinkdesignecstasyextracellularin vivoinhibitor/antagonistinsightnanodiskneuropsychiatryneurotransmissionpublic health relevancereconstitutionresearch studyserotonin transportersuccess
项目摘要
DESCRIPTION (provided by applicant): The plasmalemmal serotonin transporter (SERT) terminates serotonergic neurotransmission and thus plays a critical role in shaping the duration and magnitude of synaptic signaling. It works by coupling preexisting ion gradients to the thermodynamically unfavorable movement of serotonin from the synapse to neuronal and glial cytoplasms. This molecular machine has garnered significant clinical attention because its dysfunction has been implicated in multiple debilitating neuropsychiatric diseases such as depression, autism, obsessive- compulsive disorder, and generalized anxiety. Furthermore, it is the target of numerous psychoactive agents such as antidepressants, cocaine, and the amphetamine derivative "ecstasy". Despite such clinical and pharmacological significance, atomic-level detail into the mechanism of substrate translocation, inhibition, and regulation has remained elusive. Two goals of this proposal include 1) solving the structure of a SERT in complex with substrates, ions, and inhibitors; and 2) probing the conformational dynamics of these interactions via hydrogen-deuterium exchange mass spectrometry (HDX-MS). Structure-based hypotheses will subsequently be tested with a combination of site-directed mutagenesis, cysteine crosslinking, transient and steady-state flux kinetics, dissociation/association binding kinetics, X-ray crystallography, and HDX-MS. Success will permit further investigation into specific antagonist binding sites and perhaps into the molecular basis for drug resistance, thereby paving the way for rational drug design efforts. When eventually coupled with in vivo work beyond the scope of this proposal, SERT structure/function studies may also shed light on the molecular underpinnings of disease-associated polymorphisms. Achieving any of one of these objectives would likely have significant impact in both the laboratory and the clinic.
描述(由申请人提供):质膜血清素转运蛋白(SERT)终止血清素能神经传递,因此在塑造突触信号传导的持续时间和强度方面发挥着关键作用。它的工作原理是将预先存在的离子梯度与血清素从突触到神经元和神经胶质细胞质的热力学不利运动耦合起来。这种分子机器引起了临床的广泛关注,因为它的功能障碍与多种神经精神疾病有关,如抑郁症、自闭症、强迫症和广泛性焦虑症。此外,它还是许多精神活性药物的目标,例如抗抑郁药、可卡因和安非他明衍生物“摇头丸”。尽管具有如此的临床和药理学意义,但底物易位、抑制和调节机制的原子水平细节仍然难以捉摸。该提案的两个目标包括 1) 解决 SERT 与底物、离子和抑制剂复合物的结构; 2)通过氢-氘交换质谱(HDX-MS)探索这些相互作用的构象动力学。随后将结合定点诱变、半胱氨酸交联、瞬态和稳态通量动力学、解离/缔合结合动力学、X 射线晶体学和 HDX-MS 来测试基于结构的假设。成功将允许进一步研究特定拮抗剂结合位点,甚至可能研究耐药性的分子基础,从而为合理的药物设计工作铺平道路。当最终与超出本提案范围的体内工作相结合时,SERT 结构/功能研究也可能揭示疾病相关多态性的分子基础。实现这些目标中的任何一个都可能对实验室和临床产生重大影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SATINDER Kaur SINGH其他文献
SATINDER Kaur SINGH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SATINDER Kaur SINGH', 18)}}的其他基金
Structure and Function of a Serotonin Transporter
血清素转运蛋白的结构和功能
- 批准号:
8910786 - 财政年份:2014
- 资助金额:
$ 57.87万 - 项目类别:
Structure and Function of a Serotonin Transporter
血清素转运蛋白的结构和功能
- 批准号:
9270606 - 财政年份:2014
- 资助金额:
$ 57.87万 - 项目类别:
Structural Studies of Vesicular Monoamine Transporters
囊泡单胺转运蛋白的结构研究
- 批准号:
8360957 - 财政年份:2012
- 资助金额:
$ 57.87万 - 项目类别:
Structural Studies of Vesicular Monoamine Transporters
囊泡单胺转运蛋白的结构研究
- 批准号:
8528735 - 财政年份:2012
- 资助金额:
$ 57.87万 - 项目类别:
Transport and Inhibition in a Biogenic Amine Transporter
生物胺转运蛋白的转运和抑制
- 批准号:
7451429 - 财政年份:2008
- 资助金额:
$ 57.87万 - 项目类别:
Transport and Inhibition in a Biogenic Amine Transporter
生物胺转运蛋白的转运和抑制
- 批准号:
8272595 - 财政年份:2008
- 资助金额:
$ 57.87万 - 项目类别:
Transport and Inhibition in a Biogenic Amine Transporter
生物胺转运蛋白的转运和抑制
- 批准号:
8111165 - 财政年份:2008
- 资助金额:
$ 57.87万 - 项目类别:
Transport and Inhibition in a Biogenic Amine Transporter
生物胺转运蛋白的转运和抑制
- 批准号:
8066133 - 财政年份:2008
- 资助金额:
$ 57.87万 - 项目类别:
Transport and Inhibition in a Biogenic Amine Transporter
生物胺转运蛋白的转运和抑制
- 批准号:
7623163 - 财政年份:2008
- 资助金额:
$ 57.87万 - 项目类别:
Transport and Inhibition in a Biogenic Amine Transporter
生物胺转运蛋白的转运和抑制
- 批准号:
7871107 - 财政年份:2008
- 资助金额:
$ 57.87万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 57.87万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 57.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 57.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 57.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 57.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 57.87万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 57.87万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 57.87万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 57.87万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 57.87万 - 项目类别:
Studentship














{{item.name}}会员




